Want to join the conversation?
$VRTU expects 1Q17 revenue to be $202.5-207.5MM and non-GAAP diluted EPS to be $0.14-0.18. FY17 revenue is expected to be $890-920MM and non-GAAP diluted EPS is expected to be $2.10-2.30. The 1Q17 and FY17 diluted EPS estimates an avg. share count of approx. 30.1MM and 30.3MM, respectively, and assumes a stock price of $35.88.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?